This is a multi-center clinical trial of the anti-cytomegalovirus (CMV) monoclonal antibody (SDZ MSL-109) in infants with symptomatic congenital CMV infection without CNS manifestations. This study follows the protocol developed by the Collaborative Antiviral Study Group of the National Institute of Allergy and Infectious Diseases.
Showing the most recent 10 out of 497 publications